Skip to main content

Day: June 3, 2021

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported financial results for the quarter ended March 31, 2021. Recent HighlightsTotal revenue of $11.2 million for the first quarter of 2021, representing a 12% increase over the comparable prior year period in 2020 Initial implant revenue of $8.1 million for the first quarter of 2021, representing a 23% increase over the prior year period Completed an initial public offering of 6.9 million shares, raising approximately $105 million in net proceeds Issues 2021 total revenue guidance of approximately $47 million, representing 14% growth compared to 2020“We are pleased with our quarterly results and continue to take a measured...

Continue reading

Ceylon Graphite Announces Management Addition

VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon Graphite”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) is pleased to announce the appointment of Mr. Rodney Stevens as Vice President, Corporate Development for the Company. Mr. Stevens is a Chartered Financial Analyst (“CFA”) charterholder with over a decade of experience in the capital markets, first as an investment analyst with Salman Partners Inc. and subsequently as a merchant and investment banker. While at Salman Partners, he became a top-rated analyst as named by StarMine on July 17, 2007 for the metals and mining industry. Mr. Stevens was also a Portfolio Manager registered with Wolverton Securities Ltd. and over the course of his career, he has been instrumental in assisting in financings and mergers and acquisitions activities worth...

Continue reading

Skeljungur hf.: Deadline to submit non-binding offer for Skeljungur subsidiary P/F Magn extended to next 9 June.

Last 19 May, a notice was published to the effect that the board of directors of Skeljungur hf. had decided to invite investors to submit a non-binding offer for P/F Magn, Skeljungur’s subsidiary in the Faroe Islands; the deadline to submit offers was next 4 June. Due to increased investor interest and investors’ requests for an extended deadline, the board of Directors of Skeljungur hf. has decided to extend the deadline to submit offers for P/F Magn to next 9 June. Offers should be submitted to Kvika Bank hf.’s Corporate Finance division, Skeljungur’s advisor. The possible sale of P/F Magn is subject to the approval of a shareholders’ meeting and other conditions that the parties may set. It is uncertain what direction the matter will take, but further information will be provided as matters progress. It should be noted that the above...

Continue reading

Gilat Awarded $13M Contract by Pronatel for Delivery of Internet Services to Hundreds of Sites in Peru

Gilat to supply WI-FI services over a two-year period to the regions of Ayacucho, Apurímac, Huancavelica and CuscoGilat Addresses Critical Education Need During PandemicFirst four regions in Peru enjoy broadband provided by Gilat as part of larger government initiativePETAH TIKVA, Israel, June 03, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today the award of a $13M contract by Pronatel for delivery of internet services to hundreds of sites in Peru. Gilat to supply Public Free WI-FI services over a two-year period to the regions of Ayacucho, Apurímac, Huancavelica and Cusco with a potential for significant extension and expansion to thousands of additional sites. Gilat is engaged in support...

Continue reading

Etrion Announces Agreement to Sell the 9.5 MW Misawa Solar Project to Japanese Consortium for Total Cash Consideration of approximately JPY 1.6 billion

GENEVA, June 03, 2021 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today announced that Solar Resources Holding Sàrl and Etrion Japan K.K., wholly-owned subsidiaries of the Company, have entered into agreements (the “Transfer Agreements)” to sell their interests in the Company’s 9.5 MW Misawa operating solar energy project to a Japanese company, GK Misawa Solar, for an aggregate net purchase price of approximately JPY 1.6 billion (or USD 14.6 million), subject to certain adjustments at closing. Completion of the sale of the 9.5 MW Misawa project pursuant to the Transfer Agreements is subject to certain conditions precedent including all necessary regulatory and third-party approvals, as well as the buyer being satisfied with the Company’s recovery plan...

Continue reading

Bitfarms Announces Appointment of Chief Financial Officer, Management Promotions and Grant of Options

TORONTO, Ontario and BROSSARD, Québec, June 03, 2021 (GLOBE NEWSWIRE) — Bitfarms Ltd. (“Bitfarms”, or the “Company”) (TSXV: BITF // OTC:BFARF), today announces the appointment of Jeffrey Lucas as Chief Financial Officer, effective June 14, 2021, as well as two management promotions. Mr. Lucas brings to Bitfarms extensive international financial and operational experience with public companies listed on the NYSE and Nasdaq. He will be responsible for the oversight of the finance, accounting, and reporting functions with the mandate to raise capital, enhance our corporate communications, expand our investor relations activities, increase analyst coverage, and support and integrate acquisitions as part of building a higher level of financial and operational excellence throughout the Company. Prior to his corporate roles, Mr. Lucas...

Continue reading

Medivolve Announces Rebrand, Affirms Momentum in Health-Tech Space Under New Leadership

New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, today announced a rebrand of the company to support its evolution from investment insurer to health-tech disruptor. The new visual identity also unites all assets and subsidiaries under a single Medivolve brand umbrella, further cementing the company’s move toward a powerful, singular mission to create healthier lives. The new branding reflects the long-term strategic vision of Medivolve’s newly appointed CEO, David Preiner, underscored by momentum from a series of recent acquisitions and corporate milestones. “Medivolve’s rebranding...

Continue reading

Leslie’s, Inc. to Participate in William Blair Annual Growth Stock Conference and Raises Full Year Outlook

PHOENIX, June 03, 2021 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s” or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry announced that Mike Egeck, Chief Executive Officer, and Steve Weddell, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the William Blair Annual Growth Stock Conference today, Thursday, June 3, 2021 at 10:00 am Central Time. The Company is also raising its guidance for the full year Fiscal 2021. Mike Egeck, Chief Executive Officer, commented on recent results saying, “We are very pleased with our third quarter performance to date which has exceeded our expectations for both sales and earnings. We’ve experienced a strong start to pool season 2021 and key drivers of our outperformance...

Continue reading

Replimune Provides Data Update from its RP1 (vusolimogene oderparepvec) and RP2 Programs and Announces Plans to Expand the Development of RP2/3 Beyond Phase 1

High rate of complete responses in RP1 skin cancer cohorts underscore the potential for profound patient benefit and supports the ongoing registration directed development programs RP2 data confirms the signal with RP1 in anti-PD1 failed melanoma, uveal melanoma and in treating patients whose cancer has metastasized to the liver Announces plans to initiate broad Phase 2 development of RP2 and/or RP3 in tumor types that commonly metastasize to the liver Virtual investor event to be held at 8:00 am ET WOBURN, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced updated interim data from the Phase 2 skin cancer cohorts combining RP1 (vusolimogene oderparepvec) with Opdivo®* (nivolumab)...

Continue reading

Aleafia Health Completes Breakthrough Medical Cannabis Export to Germany

TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, is pleased to announce that dried flower grown at its Niagara greenhouse facility has been successfully exported to Germany. Gaining access to Europe’s most mature legal cannabis market is an important breakthrough for Aleafia Health, with fulfilment of successive purchase orders to Germany currently underway. Germany represents the second major medical cannabis market to which the Company has successfully completed exports. Import and export permits have been secured for two additional orders to Australia, with the shipments expected to occur in June. “The investments we’ve made in the highest levels of global regulatory compliance are just now beginning...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.